Disproportionality Analysis is a method used in pharmacovigilance to examine databases containing Individual Case Safety/Study Reports (ICSRs). This analysis involves screening for statistical associations between specific medical products and adverse events, with a focus on identifying cases where the observed frequency of these associations significantly differs from the expected frequency based on historical or background data. This approach helps to pinpoint potential safety concerns and patterns that may require further investigation and regulatory action.
Confounding by Indication
Contact our experts today
Composed of proven experts from the pharmaceutical industry, our team is ready to answer to your needs in any
area of product development, commercialisation and early access programs, and life cycle management